Skip to main content
. 2015 Dec 28;12:S1–S110. doi: 10.1111/j.1470-9465.2006.12_4_1426.x
Study Clinical response PP (%) Diff (95% CI) Clinical Response ITT (%) Dlff (95% CI) Clinical Response – Microb Evaluable (%)
1 FM
224/246 (91.1)
−0.1 (−5.3, 5.0) 258/298 (86.6)
0.5 (−5.1, 6.0) 139/154 (90.3)
1 AC 207/227 (91.2) 254/295 (86.1) 125/139 (89.9)

2 FM
210/246 (85.4)
−6.5 (−12.1, −0.9) 220/296 (74.3)
−4.1 (−10.9, 2 8) 132/151 (87.4)
2 C 226/246 (91.9) 228/291 (78.4) 139/150 (92.7)

All FM
434/492 (88.2)
−3.3 (−7.1, 0.5) 478/594 (80.5)
−1.8 (−6.2, 2.7) 271/305 (88.9)
Comp 433/473 (91.5) 482/586 (32.3) 264/289 (91.3)